Maqsood Yaqub

Amsterdam University Medical Centers

Papers

1

Total Citations

27

H-Index

1

About

Maqsood Yaqub is a leading researcher in the field of nuclear medicine and molecular imaging, with a primary focus on advancing the diagnosis and management of prostate cancer. His key research areas include the development and clinical validation of PSMA-targeted PET imaging, particularly the use of [18F]DCFPyL, and its integration with multiparametric MRI. Dr. Yaqub’s major contribution is his pioneering work in demonstrating the superior accuracy of PSMA-PET/MRI over conventional mpMRI for detecting clinically significant prostate cancer. His landmark study, the ProStaPET trial, provided critical evidence that hybrid imaging can more precisely localize aggressive tumors, directly impacting surgical planning and biopsy guidance. This work, which has accumulated 27 citations, is highly influential in shaping modern prostate cancer imaging protocols. Dr. Yaqub’s research bridges the gap between advanced imaging technology and clinical practice, offering tangible improvements in patient outcomes. His contributions are recognized as foundational in the shift toward more personalized, non-invasive cancer diagnostics, making him a key figure in the evolution of oncologic imaging.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study
27 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Amsterdam University Medical Centers

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago